Archive for November, 2014

Recent Rosacea Blog Posts

Actavis to trial Mirvaso competitor

An interesting development in rosacea clinical trials is the emergence of a new company called Actavis. Actavis have listed a large trial where they plan to test their Brimonidine Gel against Galderma’s recently FDA approved Brimonidine-based Mirvaso Gel. The large Phase 3 trial will compare the response after 7 days. Up to 462 patients in […]

Continue Reading

Farmaka Rosacea Cream (Dermalex) Improves Redness

Further to the gentle market launch of Dermalex Repair Cream is some vendor sponsored research into how well Farmaka Rosacea Cream (FRC) treats the redness and general dryness of rosacea. So What is Farmaka Rosacea Cream?

Continue Reading

Gladskin Rosacea Cream and Gel, Staphefekt in a topical

Seeking to create products based on the recently publicised MRSA-killing topical Staphefekt are some topical creams to treat rosacea, acne, eczema and general skin irritation.

Continue Reading

Staphefekt: New antibiotic topical kills MRSA

Lots of mainstream media attention this week relating to a new type of antibiotic that is able to kill that increasingly resistant bacteria MRSA. The small patient trial was able to demonstrate that this new enzyme derived from a virus that infects bacteria, was able to clear MRSA skin infections. What does this mean to […]

Continue Reading

Another Demodex Bacteria Isolated: Bartonella quintana

In a short paper, researchers have detailed the investigation into demodex mite bacteria that was able to isolate another pathogenic bacteria. This time the bacteria is known as Bartonella quintana. B. quintana can now join B. oleronius bacteria directly linked to demodex mites. Here is what you need to know.

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.